Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × TB-403 × Clear all

NCT01308723 2016-11-02

A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular